FCGR1A and tuberculosis: Importantly, in HIV-coinfected TB patients, transcriptomic profiles of ATT treatment responses (including expression of FCGR1A) were identified that were not affected by highly active antiretroviral therapy, and that normalized to levels observed in HIV+ latently TB infected and uninfected controls after completion of ATT (see text footnote 1).